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PCS scales implied a 1.02-1.04 RR of hospitalization, a 1.07-1.15 RR of being 
unable to work, and a 1.04-1.06 RR of losing the ability to work. CONCLUSIONS: 
Statistical associations with outcomes such as mortality, hospitalization, and 
work ability can be used as benchmarks to interpret score differences on the SF-
36.  
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OBJECTIVES: To map levels of the Health Status Classification System – 
Preschool (HSCS-PS) into the Health Utilities (HUI) Mark 2 (HUI2) and Mark 3 
(HUI3) measurement systems. This will create a generic utility-based measure of 
health-related quality of life (HRQL) applicable to all persons 2.5 years of age and 
older. METHODS: The existing HSCS-PS is based on the HUI2 and HUI3 (HUI2/3) 
classification systems. The attribute levels of the HSCS-PS were mapped into the 
HUI classification systems attribute levels and, by extension, to the existing HUI 
scoring functions for calculating HRQL utility scores. A questionnaire was 
developed asking participants to map level descriptions between matched HSCS-
PS and HUI2/3 attributes. Mapping questionnaires were completed by 14 health 
care professionals (6 nurses and 8 physicians) responsible for the care of pre-
school aged children diagnosed with cancer or developmental problems. Percent 
exact agreement was calculated among participants for each set of HSCS-PS level 
mappings. Differences in proportions of level mappings within each HSCS-PS 
attribute were tested using Fisher’s exact test. Strength of agreement was 
described as follows: “exact wording assignment” or >70.0% “very strong”; 50.0 to 
69.9% “strong”, 40.0 to 49.9% “moderate”. RESULTS: A total of 41 levels from 10 
attributes of the HSCS-PS were mapped to 19 levels in 5 HUI2 attributes and 33 
levels in 8 HUI3 attributes (total=52). Differences in mapping proportions were 
significant (p<0.001) for all 12 sets of levels. Agreement was very strong for 86.5% 
(n=45), strong for 11.5% (n=6), and moderate for the remaining 2.0% (n=1) of the 
mappings. CONCLUSIONS: There was strong to very strong agreement among 
health care professionals about the overwhelming majority of the mappings of 
HSCS-PS to HUI2/3 attribute levels. Future work will repeat the mapping exercise 
with parents of preschool children in general and clinical populations, and 
include validation studies.  
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OBJECTIVES: Traditional Time trade off (TTO) method was used in EQ-5D social 
valuation protocols, and it has some known problems in the valuation of health 
states considered worse than dead. The aim of our study is to compare two TTO 
variants trying to overcome this issue: lead-time and lag-time TTO. METHODS: 
Quota sampling was undertook in June 2011 in Buenos Aires, as part of the EQ-
5D-5L Multinational Pilot Study. Respondents were randomly assigned to one of 
the TTO variants with two blocks of 5 EQ-5D-5L health states. Tasks were 
administered using a web based digital aid (EQ-VT) administered in a group 
interview. RESULTS: A total of 387 participants were included (mean age 38.85 
[SD: 13.97]; 53.14% females). The mean observed values ranged from 0.44 (0.59) 
for the state 21111 to 0.02 (0.76) for the 53555 in the lead-time group and between 
0.53 (0.52) and 0.08 (0.76) in lag-time group. There were no statistically significant 
differences in the values between TTO variants, except for a significant 
difference of 0.19 for state 33133. In both variants marked peaks were observed 
around the value 0 across all states. We also found evidence of an order effect 
with a greater percentage of responses U=0 in the 5th state valuated compared 
with the first (16.2% to 27.1% in lead-time; 13.71 to 23.32 in lag-time). There were 
no differences regarding process indicators or cognitive debriefing. 
CONCLUSIONS: No important differences were found between TTO variants 
regarding values for EQ-5D-5L health states, which suggest that they could be 
equivalent.  
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OBJECTIVES: Low medication adherence is a serious, but preventable, issue 
facing health care services today. Although health care providers are 
accountable to provide appropriate information to patients regarding their 
medication treatment, patients’ ability to understand the information in the 
process of provider-patient communication has been overlooked. Using a 
systematic literature review and subsequent meta-analysis, this study evaluates 
the impact of health literacy as a predictor of medication adherence among 
patients with chronic diseases. METHODS: Articles were identified through 
literature searches conducted on MEDLINE, PUBMED, CINAHL, PsycInfo, 
International Pharmaceutical Abstracts, Web of Sciences, and review of 
reference citations. Methodological variables, effect sizes of associations, 
diseases, and measures of health literacy and medication adherence were 
abstracted from each eligible article. Studies were categorized by disease 
category, statistical methods and significance (bivariate or multivariate 
significance and insignificance), literacy and adherence outcome metrics. The 
population effect size of the association between health literacy and medication 
adherence are estimated based on simulation based meta-analysis. RESULTS: 
Across 29 studies, 47% multivariate studies and 80% bivariate studies reported 
that higher health literacy levels were statistically significantly associated with 
better adherence to prescribed medications. There was wide variation on the 
association between health literacy and medication adherence across diseases. 
For example, 75% of studies on diabetes reported no statistical associations 
between health literacy and medication adherence, while 100% of studies on 
glaucoma reported statistical associations. The Monte Carlo simulation based 
meta-analysis found that a statistically significant association between health 
literacy and medication adherence (p<0.001), although the unweighted 
population effect size is relatively small (r=0.122 with a 95% confidence interval 
of (0.0849, 0.159). CONCLUSIONS: Health literacy is a proven predictor of 
medication adherence, and it is more potent in some diseases than others. 
Adherence intervention may focus on patients’ health literacy in the provider-
patient communications and health information exchange.  
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OBJECTIVES: This study evaluated the psychometric properties of the FACIT-
Fatigue patient-reported outcome (PRO) instrument (Yellen et al., 1997) in 
patients with iron deficiency anemia (IDA). METHODS: As part of a randomized, 
controlled clinical trial IDA patients (n=808) completed the FACIT-Fatigue, Linear 
Analogue Scale Assessments (LASAs), and Medical Outcomes Study Short-Form 
36 (SF-36) PRO instruments at five weekly visits. Baseline and Week 3 data, 
including hemoglobin, were used to validate the FACIT-Fatigue scale in this IDA 
patient population. RESULTS: The FACIT-Fatigue showed little to no ceiling or 
floor effects and produced reasonable response variability across items. Further, 
test-retest reliability (ICC=.87) and internal consistency reliability (Baseline α=.93) 
were both acceptable. Hypothesized convergent validity associations between 
other PROs and the fatigue scale were largely supported, although the 
hemoglobin-fatigue association was not as strong as expected (Baseline r =0.04; 
ns, Week 3 r=0.15; p<0.001). As predicted, known-groups validity showed that 
patients receiving intravenous iron treatment with ferumoxytol reported less 
fatigue than their placebo-treated counterparts (p<0.001). Further, a series of t-
tests showed that patients with severely low hemoglobin levels reported 
significantly greater fatigue than those with mild, moderate, and severe values 
(ps<0.05). Finally, the FACIT-Fatigue demonstrated ability to detect change using 
the SF-36 Vitality domain as a PRO anchor. Specifically, patients with worsened 
vitality reported worsened fatigue (ns), whereas patients grouped according to 
much, moderate, and minimal vitality improvements reported fatigue 
improvements (all ps<0.001; effect sizes increasing across groups accordingly). 
CONCLUSIONS: This study demonstrated that the FACIT-Fatigue provides a 
psychometrically valid assessment of fatigue in patients with IDA. Specifically, 
the scale was reproducible and internally consistent in an IDA population and 
exhibited construct validity in terms of predicted convergent/discriminant 
correlations and across known groups. Finally, the FACIT-Fatigue was able to 
detect change when change occurred in a PRO anchor.  
 
PRM131  
PSYCHOMETRIC PERFORMANCE OF THE NEI VFQ-25: RECOMMENDATIONS FOR 
A MODIFIED VERSION OF THE 25-ITEM NATIONAL EYE INSTITUTE 
QUESTIONNAIRE (NEI VFQ-25) BASED ON RASCH ANALYSIS USING CLINICAL 
TRIALS DATA ACROSS FOUR RETINAL DISEASES  
Lamoureux E1, Lee P2, Petrillo J3, Ferreira A4, Cano S5, Bressler NM6 
1University of Melbourne, Melbourne, Australia, 2University of Michigan, Ann Arbor, MI, USA, 
3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 4Novartis Pharma AG, Basel, 
Switzerland, 5ScaleReport, Stotfold, UK, 6John Hopkins University School of Medicine, Baltimore, 
MD, USA  
OBJECTIVES: Previous Rasch analysis on the National Eye Institute Visual 
Function Questionnaire (NEI VFQ-25) has suggested that a modified instrument 
may provide improved coverage and targeting of patient-reported visual function 
for patients with eye diseases. The aims of this study were to propose a Rasch-
based scoring structure, the NEI VFQ-25-R, and to assess its psychometric 
performance. METHODS: The NEI VFQ-25-R was developed by combining 
response levels for disordered thresholds for 15 NEI VFQ-25 items, excluding four 
poorly fitting items and including six optional near and distance subscale items. 
NEI VFQ-25-R items were regrouped into two subscales, Activity Limitation and 
Socio-Emotional Impact, based on literature, item face validity and clinician 
input. Performance was evaluated using Rasch analysis by assessing item fit 
validity, threshold targeting, item dependency, and reliability using pooled 
baseline data (2487 person measurements) from six clinical trials across four 
retinal diseases. RESULTS: No disordered thresholds were observed for any NEI 
VFQ-25-R items, and only three misfitting items were reported. The estimated 
Person Separation Index was 0.94, suggesting good reliability. Only two items 
had a residual correlation >0.30, demonstrating minimal local dependency 
between items. Distribution of item thresholds revealed a reduced ceiling effect 
compared with the NEI VFQ-25. Threshold targeting was better for patients with 
neovascular age-related macular degeneration, lower visual acuity, and low 
reported visual function. CONCLUSIONS: Collapsing disordered response 
categories and excluding misfitting items improved psychometric performance 
for the NEI VFQ-25-R compared with the NEI VFQ-25. The reduced ceiling effect 
